BiotechTube
BAG Diagnostics

BAG Diagnostics

Lich, Germany· Est.
bag-diagnostics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

BAG Diagnostics is a long-established, privately-owned German diagnostics company with a 75+ year history. Its core expertise lies in immunohaematology and histocompatibility, offering a comprehensive portfolio for safe blood transfusions and organ transplants. The company has expanded its portfolio to include molecular infectious disease testing, notably with its ViroQ® real-time PCR line developed during the COVID-19 pandemic. BAG operates with a customer-centric philosophy, focusing on developing high-quality, reliable diagnostic kits and automated systems for clinical laboratories.

Transplantation MedicineTransfusion MedicineInfectious DiseasesHuman Genetics

Technology Platform

Integrated serological and molecular genetic diagnostics platform. Includes Sequence-Specific Primer (SSP) PCR, Real-Time PCR (qPCR), Sequence-Specific Oligonucleotide (SSO) probe technology, Luminex-based assays, and serological reagent/automated evaluation systems for immunohaematology and histocompatibility testing.

Opportunities

The growing global volume of transplants and blood transfusions drives steady demand for its core typing and antibody detection kits.
The expansion of its ViroQ® real-time PCR platform into broader infectious disease testing (e.g., respiratory panels, outbreak response) represents a significant adjacent market opportunity beyond its traditional immunology focus.

Risk Factors

Intense competition from large, global IVD conglomerates and other specialized firms could pressure market share and pricing.
Technological disruption, such as the adoption of next-generation sequencing (NGS) for HLA typing, requires continuous R&D investment to keep the product portfolio competitive.
Navigating the increasingly complex EU IVDR and other global regulatory landscapes poses a significant compliance cost and hurdle.

Competitive Landscape

BAG competes in specialized niches against large players like Thermo Fisher (One Lambda), Immucor, Bio-Rad, and Roche in transplantation and transfusion diagnostics. In molecular infectious disease testing, it faces intense competition from giants like Roche, Abbott, and Seegene. Its differentiation lies in its deep niche expertise, customer partnership model, and agility as a private, focused company.

More companies in Diagnostics & Precision Medicine →More companies in Germany →